Ex vivo

Results: 78



#Item
41DOI:[removed].CAN[removed]Ex Vivo Expansion of CD8+CD56+ and CD8+CD56− Natural Killer T Cells Specific for MUC1 Mucin Howard J. Wajchman, Carl W. Pierce, Vijay A. Varma, et al. Cancer Res 2004;64:[removed]Pub

DOI:[removed].CAN[removed]Ex Vivo Expansion of CD8+CD56+ and CD8+CD56− Natural Killer T Cells Specific for MUC1 Mucin Howard J. Wajchman, Carl W. Pierce, Vijay A. Varma, et al. Cancer Res 2004;64:[removed]Pub

Add to Reading List

Source URL: strokedoctor.com

Language: English - Date: 2012-04-05 13:41:33
42Corners In November of 2014 the American Society for Cellular and Computational Toxicology held its 3rd annual scientific and business meeting, Where Chemistry and Biology Meet: AOPs as a Framework for Advancing Toxicol

Corners In November of 2014 the American Society for Cellular and Computational Toxicology held its 3rd annual scientific and business meeting, Where Chemistry and Biology Meet: AOPs as a Framework for Advancing Toxicol

Add to Reading List

Source URL: www.altex.ch

Language: English - Date: 2015-01-19 02:40:33
43Direkter ex vivo Nachweis Myelin Basic Protein (MBP)-spezifischer T-Helferzellen bei Multiple Sklerose Patienten

Direkter ex vivo Nachweis Myelin Basic Protein (MBP)-spezifischer T-Helferzellen bei Multiple Sklerose Patienten

Add to Reading List

Source URL: edoc.hu-berlin.de

Language: German - Date: 2009-10-31 18:13:58
    44Schwerpunkte der Effektbewertung und Expositionsabschätzung und neue Ansätze zur toxicologischen Bewertung

    Schwerpunkte der Effektbewertung und Expositionsabschätzung und neue Ansätze zur toxicologischen Bewertung

    Add to Reading List

    Source URL: circabc.europa.eu

    Language: English
    45Version: [removed]Indiana University School of Medicine Institutional Animal Care and Use Committee (IACUC) Animal Protocol Review Form Protocol Number:

    Version: [removed]Indiana University School of Medicine Institutional Animal Care and Use Committee (IACUC) Animal Protocol Review Form Protocol Number:

    Add to Reading List

    Source URL: researchcompliance.iu.edu

    Language: English - Date: 2014-10-03 14:58:17
    46Fraunhofer Institute for T o x ic o l o g y a n d E x p e r i m e n t a l M e d ici n e I TEM The Fraunhofer ITEM offers contract research in the area of human health. The focus of research is

    Fraunhofer Institute for T o x ic o l o g y a n d E x p e r i m e n t a l M e d ici n e I TEM The Fraunhofer ITEM offers contract research in the area of human health. The focus of research is

    Add to Reading List

    Source URL: www.item.fraunhofer.de

    Language: English - Date: 2015-01-16 06:12:14
    47Subject Matter: Lessons from Cancer FROM CANCER TO HIV-1: REPURPOSING KINASE INHIBITORS TO REDUCE HIV-1 INFECTION EX VIVO Stephen McCarthy 1; Darinka Sakac 2; Anton Neschadim 3; Donald Branch 1, 2, 3, 4; 1 Department of

    Subject Matter: Lessons from Cancer FROM CANCER TO HIV-1: REPURPOSING KINASE INHIBITORS TO REDUCE HIV-1 INFECTION EX VIVO Stephen McCarthy 1; Darinka Sakac 2; Anton Neschadim 3; Donald Branch 1, 2, 3, 4; 1 Department of

    Add to Reading List

    Source URL: backtobasic.ohtn.on.ca

    Language: English - Date: 2014-11-03 14:04:14
    48Our research is focused on realizing a physiologically relevant ex vivo human model, exploring the frontiers of bioprinting, and creating neural interfaces to unravel the mysteries of the human brain and develop novel th

    Our research is focused on realizing a physiologically relevant ex vivo human model, exploring the frontiers of bioprinting, and creating neural interfaces to unravel the mysteries of the human brain and develop novel th

    Add to Reading List

    Source URL: engineering.llnl.gov

    Language: English - Date: 2014-10-17 20:45:29
    49TELOMICSTM ex vivo Robotics – Automatisiertes Gewebescreening IFF Fraunhofer Institut

    TELOMICSTM ex vivo Robotics – Automatisiertes Gewebescreening IFF Fraunhofer Institut

    Add to Reading List

    Source URL: www.iff.fraunhofer.de

    Language: German - Date: 2014-12-05 16:27:25
      50PROTOCOL HGB-204 A Phase 1/2, Open Label Study Evaluating the Safety and Efficacy of Gene Therapy in Subjects with β-Thalassemia Major by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo with a Lentivi

      PROTOCOL HGB-204 A Phase 1/2, Open Label Study Evaluating the Safety and Efficacy of Gene Therapy in Subjects with β-Thalassemia Major by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo with a Lentivi

      Add to Reading List

      Source URL: osp.od.nih.gov

      Language: English - Date: 2013-12-30 15:20:40